- Arcos Dorados Holdings Inc (NYSE:ARCO) reported third-quarter FY22 sales growth of 27% year-on-year to $921.7 million, beating the consensus of $902.19 million.
- Excluding Venezuela, Consolidated revenue totaled $916.3 million, rising 26.7% in U.S. dollars and 38.9% in constant currency.
- Systemwide comparable sales grew 34.2% Y/Y, Excluding Venezuela, driven primarily by higher guest traffic and market share gains across the region.
- The operating margin was 8%, and the operating income for the quarter was $73.9 million.
- Adjusted EBITDA for the quarter was $102.65 million with an adjusted EBITDA margin of 11.2%, down 120 basis points versus last year.
- EPS of $0.22 beat the analyst consensus of $0.11.
- The company held $319.1 million in cash and equivalents as of September 30, 2022.
- Price Action: ARCO shares are trading higher by 7.67% at $7.86 on the last check Wednesday.
Novo Nordisk’s Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug.
